Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire
Launched by PROF. DR. CEMIL TASCIOGLU EDUCATION AND RESEARCH HOSPITAL ORGANIZATION · Jul 7, 2025
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • Primary caregiver of a child under the age of 18
- • Child must have a documented history of drug hypersensitivity
- • Fluent in written and spoken Turkish
- • Willingness to participate and provide written informed consent
- • Availability to complete both baseline and follow-up questionnaire within the designated time frame
- Exclusion Criteria:
- • Caregivers with diagnosed psychiatric or cognitive disorders
- • Inability to read or write in Turkish
- • Child currently experiencing an acute drug hypersensitivity reaction
- • Previous participation in the pilot testing phase of this validation study
About Prof. Dr. Cemil Tascıoglu Education And Research Hospital Organization
Prof. Dr. Cemil Taşcıoğlu Education and Research Hospital Organization is a leading clinical research institution dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a strong focus on education and collaboration, the organization fosters an environment conducive to clinical trials that address pressing health challenges. It is committed to ethical standards and rigorous scientific methodologies, ensuring the safety and well-being of participants while contributing to the development of new therapies and treatments. The hospital's multidisciplinary team of experts works closely with healthcare professionals and researchers to translate findings into practical applications that enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported